PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.73 | 5.46
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
9.31%
Revenue growth similar to ADI's 8.95%. Walter Schloss would see if both companies share industry tailwinds.
11.33%
Gross profit growth at 75-90% of ADI's 12.68%. Bill Ackman would demand operational improvements to match competitor gains.
14.74%
Positive EBIT growth while ADI is negative. John Neff might see a substantial edge in operational management.
18.05%
Operating income growth under 50% of ADI's 37.99%. Michael Burry would be concerned about deeper cost or sales issues.
9.84%
Net income growth under 50% of ADI's 45.60%. Michael Burry would suspect the firm is falling well behind a key competitor.
10.85%
EPS growth under 50% of ADI's 45.57%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
10.16%
Diluted EPS growth under 50% of ADI's 46.15%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.22%
Share reduction while ADI is at 0.01%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.44%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-0.02%
Dividend reduction while ADI stands at 7.59%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
119.08%
Positive OCF growth while ADI is negative. John Neff would see this as a clear operational advantage vs. the competitor.
302.55%
Positive FCF growth while ADI is negative. John Neff would see a strong competitive edge in net cash generation.
56.74%
10Y revenue/share CAGR at 50-75% of ADI's 102.63%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
38.54%
5Y revenue/share CAGR at 75-90% of ADI's 48.76%. Bill Ackman would encourage strategies to match competitor’s pace.
-13.53%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
158.33%
10Y OCF/share CAGR above 1.5x ADI's 50.10%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
9.09%
Below 50% of ADI's 41.75%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
6.59%
Positive 3Y OCF/share CAGR while ADI is negative. John Neff might see a big short-term edge in operational efficiency.
111.90%
Net income/share CAGR 1.25-1.5x ADI's 74.85%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
-5.33%
Negative 5Y net income/share CAGR while ADI is 57.95%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-42.73%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
83.06%
Below 50% of ADI's 344.42%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
116.48%
5Y equity/share CAGR is in line with ADI's 124.16%. Walter Schloss would see parallel mid-term profitability and retention policies.
17.94%
Positive short-term equity growth while ADI is negative. John Neff sees a strong advantage in near-term net worth buildup.
297.32%
10Y dividend/share CAGR above 1.5x ADI's 147.77%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
51.38%
5Y dividend/share CAGR at 75-90% of ADI's 59.40%. Bill Ackman wants more robust earnings or a higher payout ratio to match the competitor.
18.05%
3Y dividend/share CAGR at 50-75% of ADI's 30.04%. Martin Whitman might see a weaker short-term approach to distributing cash.
-36.69%
Firm’s AR is declining while ADI shows 15.93%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
2.67%
Inventory growth well above ADI's 3.41%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
3.48%
Positive asset growth while ADI is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
0.20%
Positive BV/share change while ADI is negative. John Neff sees a clear edge over a competitor losing equity.
9.30%
We have some new debt while ADI reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
1.93%
R&D dropping or stable vs. ADI's 9.67%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
2.75%
SG&A declining or stable vs. ADI's 6.28%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.